nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.07.2023 | Original Article

A first-trimester serum TSH in the 4–10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women

verfasst von: F. Magri, C. Bellingeri, I. De Maggio, L. Croce, F. Coperchini, M. Rotondi, L. Chiovato, A. Spinillo, F. Beneventi

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 7/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The impact of mild subclinical hypothyroidism on pregnancy outcomes in TPOAb-negative women is poorly explored. The aim of the present study was the evaluation in a wide cohort of TPOAb-negative pregnant women the role of subclinical hypothyroidism (SCH) on several pregnancy outcomes.

Methods

The study included women aged ≥ 18 years with a singleton pregnancy without known thyroid disease with serum TSH concentration between 0.4 and 10 mIU/L and TPOAb negative. Data about clinical and demographic features were collected. A blood sample was drown to test TSH, TPOAb, ANA and ENA concentration. The mean uterine artery pulsatility index was measured. Risk of adverse obstetric and fetal outcomes was collected.

Results

The cohort included 2135 pregnant women. Pregnant women with TSH 4–10 mUI/L had a significantly higher frequency of family history of thyroid diseases, and personal history of celiac disease diseases, type 1 diabetes mellitus, rheumatic disease, antinuclear antibody (ANA) and anti-extractable nuclear antigen (ENA) positive tests. The risk for pre-eclampsia and small for gestational age (SGA) was significantly higher in pregnant women with first-trimester TSH 4–10 mIU/L. A first-trimester TSH serum level greater than 4 mIU/L was associated with a significant increase in the occurrence of abnormal uterine artery pulsatility index, with a more than threefold increase in the risk of developing pre-eclampsia and with the risk of SGA.

Conclusions

In TPOAb-negative pregnant women, a first-trimester serum TSH level ranging from 4 to 10 mIU/L is significantly and independently linked to an increased uterine artery pulsatility index as well as to negative pregnancy outcomes such as pre-eclampsia, SGA and gestational diabetes.

Nur mit Berechtigung zugänglich

Alexander EK, Pearce EN, Brent GA, Brown RS, Chen H, Dosiou C, Grobman WA, Laurberg P, Lazarus JH, Mandel SJ, Peeters RP, Sullivan S (2017) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid 27(3):315–389. https://doi.org/10.1089/thy.2016.0457CrossRefPubMed

Rotondi M, Chiovato L, Pacini F, Bartalena L, Vitti P (2018) Management of subclinical hypothyroidism in pregnancy: a comment from the Italian Society of Endocrinology and the Italian Thyroid Association to the 2017 American Thyroid Association Guidelines—"The Italian Way". Thyroid 28(5):551–555. https://doi.org/10.1089/thy.2017.0424CrossRefPubMed

Lazarus J, Brown RS, Daumerie C, Hubalewska-Dydejczyk A, Negro R, Vaidya B (2014) 2014 European thyroid association guidelines for the management of subclinical hypothyroidism in pregnancy and in children. Eur Thyroid J 3(2):76–94. https://doi.org/10.1159/000362597CrossRefPubMedPubMedCentral

Leung AS, Millar LK, Koonings PP, Montoro M, Mestman JH (1993) Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 81(3):349–353PubMed

Idris I, Srinivasan R, Simm A, Page RC (2005) Maternal hypothyroidism in early and late gestation: effects on neonatal and obstetric outcome. Clin Endocrinol (Oxf) 63(5):560–565. https://doi.org/10.1111/j.1365-2265.2005.02382.xCrossRefPubMed

Liu H, Shan Z, Li C, Mao J, Xie X, Wang W, Fan C, Wang H, Zhang H, Han C, Wang X, Liu X, Fan Y, Bao S, Teng W (2014) Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study. Thyroid 24(11):1642–1649. https://doi.org/10.1089/thy.2014.0029CrossRefPubMedPubMedCentral

Benhadi N, Wiersinga WM, Reitsma JB, Vrijkotte TG, Bonsel GJ (2009) Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol 160(6):985–991. https://doi.org/10.1530/EJE-08-0953CrossRefPubMed

Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Stagnaro-Green A (2010) Increased pregnancy loss rate in thyroid antibody negative women with TSH levels between 25 and 50 in the first trimester of pregnancy. J Clin Endocrinol Metab 95(9):E44–E48. https://doi.org/10.1210/jc.2010-0340CrossRefPubMed

Korevaar TI, Schalekamp-Timmermans S, de Rijke YB, Visser WE, Visser W, de Muinck Keizer-Schrama SM, Hofman A, Ross HA, Hooijkaas H, Tiemeier H, Bongers-Schokking JJ, Jaddoe VW, Visser TJ, Steegers EA, Medici M, Peeters RP (2013) Hypothyroxinemia and TPO-antibody positivity are risk factors for premature delivery: the generation R study. J Clin Endocrinol Metab 98(11):4382–4390. https://doi.org/10.1210/jc.2013-2855CrossRefPubMed

10.

Stagnaro-Green A, Abalovich M, Alexander E, Azizi F, Mestman J, Negro R, Nixon A, Pearce EN, Soldin OP, Sullivan S, Wiersinga W, American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum (2011) Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 21(10):1081–1125. https://doi.org/10.1089/thy.2011.0087CrossRefPubMedPubMedCentral

11.

Lee SY, Cabral HJ, Aschengrau A, Pearce EN (2020) Associations between maternal thyroid function in pregnancy and obstetric and perinatal outcomes. J Clin Endocrinol Metab 105(5):e2015–e2023. https://doi.org/10.1210/clinem/dgz275CrossRefPubMed

12.

Sheehan PM, Nankervis A, Araujo Júnior E, Da Silva CF (2015) Maternal thyroid disease and preterm birth: systematic review and meta-analysis. J Clin Endocrinol Metab 100(11):4325–4331. https://doi.org/10.1210/jc.2015-3074CrossRefPubMed

13.

Männistö T, Vääräsmäki M, Pouta A, Hartikainen AL, Ruokonen A, Surcel HM, Bloigu A, Järvelin MR, Suvanto-Luukkonen E (2009) Perinatal outcome of children born to mothers with thyroid dysfunction or antibodies: a prospective population-based cohort study. J Clin Endocrinol Metab 94(3):772–779. https://doi.org/10.1210/jc.2008-1520CrossRefPubMed

14.

Consortium on Thyroid and Pregnancy—Study Group on Preterm Birth, Korevaar TIM, Derakhshan A, Taylor PN, Meima M, Chen L, Bliddal S, Carty DM, Meems M, Vaidya B, Shields B, Ghafoor F, Popova PV, Mosso L, Oken E, Suvanto E, Hisada A, Yoshinaga J, Brown SJ, Bassols J, Auvinen J, Bramer WM, López-Bermejo A, Dayan C, Boucai L, Vafeiadi M, Grineva EN, Tkachuck AS, Pop VJM, Vrijkotte TG, Guxens M, Chatzi L, Sunyer J, Jiménez-Zabala A, Riaño I, Murcia M, Lu X, Mukhtar S, Delles C, Feldt-Rasmussen U, Nelson SM, Alexander EK, Chaker L, Männistö T, Walsh JP, Pearce EN, Steegers EAP, Peeters RP (2019) Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis. JAMA 322(7):632–641. https://doi.org/10.1001/jama.2019.10931CrossRef

15.

Beneventi F, De Maggio I, Bellingeri C, Cavagnoli C, Spada C, Boschetti A, Magri F, Spinillo A (2022) Thyroid autoimmunity and adverse pregnancy outcomes: a prospective cohort study. Endocrine 76(1):198–207. https://doi.org/10.1007/s12020-021-02958-wCrossRefPubMed

16.

Pearce EN, Oken E, Gillman MW, Lee SL, Magnani B, Platek D, Braverman LE (2008) Association of first-trimester thyroid function test values with thyroperoxidase antibody status, smoking, and multivitamin use. Endocr Pract 14(1):33–39. https://doi.org/10.4158/EP.14.1.33CrossRefPubMedPubMedCentral

17.

Blatt AJ, Nakamoto JM, Kaufman HW (2012) National status of testing for hypothyroidism during pregnancy and postpartum. J Clin Endocrinol Metab 97(3):777–784. https://doi.org/10.1210/jc.2011-2038CrossRefPubMed

18.

Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H (2006) Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 91(7):2587–2591. https://doi.org/10.1210/jc.2005-1603CrossRefPubMed

19.

Thangaratinam S, Tan A, Knox E, Kilby MD, Franklyn J, Coomarasamy A (2011) Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 9(342):d2616. https://doi.org/10.1136/bmj.d2616CrossRef

20.

Glinoer D, Riahi M, Grün JP, Kinthaert J (1994) Risk of subclinical hypothyroidism in pregnant women with asymptomatic autoimmune thyroid disorders. J Clin Endocrinol Metab 79(1):197–204. https://doi.org/10.1210/jcem.79.1.8027226CrossRefPubMed

21.

He X, Wang P, Wang Z, He X, Xu D, Wang B (2012) Thyroid antibodies and risk of preterm delivery: a meta-analysis of prospective cohort studies. Eur J Endocrinol 167(4):455–464. https://doi.org/10.1530/EJE-12-0379CrossRefPubMed

22.

De Leo S, Pearce EN (2018) Autoimmune thyroid disease during pregnancy. Lancet Diabetes Endocrinol 6(7):575–586. https://doi.org/10.1016/S2213-8587(17)30402-3CrossRefPubMed

23.

Zhu P, Chu R, Pan S, Lai X, Ran J, Li X (2021) Impact of TPOAb-negative maternal subclinical hypothyroidism in early pregnancy on adverse pregnancy outcomes. Ther Adv Endocrinol Metab. https://doi.org/10.1177/20420188211054690CrossRefPubMedPubMedCentral

24.

Chen J, Zhu J, Huang X, Zhao S, Xiang H, Zhou P, Zhou T, Xu Z (2022) Subclinical hypothyroidism with negative for thyroid peroxidase antibodies in pregnancy: intellectual development of offspring. Thyroid 32(4):449–458. https://doi.org/10.1089/thy.2021.0374CrossRefPubMed

25.

Plowden TC, Schisterman EF, Sjaarda LA, Perkins NJ, Silver R, Radin R, Kim K, Galai N, DeCherney AH, Mumford SL (2017) Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes. Am J Obstet Gynecol 217(6):697.e1-697.e7. https://doi.org/10.1016/j.ajog.2017.09.001CrossRefPubMed

26.

Spinillo A, Beneventi F, Ramoni V, Caporali R, Locatelli E, Simonetta M, Cavagnoli C, Alpini C, Albonico G, Prisco E, Montecucco C (2012) Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy. Ann Rheum Dis 71(6):918–923. https://doi.org/10.1136/annrheumdis-2011-154146CrossRefPubMed

27.

Bhide A, Acharya G, Bilardo CM, Brezinka C, Cafici D, Hernandez-Andrade E, Kalache K, Kingdom J, Kiserud T, Lee W, Lees C, Leung KY, Malinger G, Mari G, Prefumo F, Sepulveda W, Trudinger B (2013) ISUOG practice guidelines: use of Doppler ultrasonography in obstetrics. Ultrasound Obstet Gynecol 41(2):233–239. https://doi.org/10.1002/uog.12371CrossRefPubMed

28.

Frusca T, Soregaroli M, Valcamonico A, Guandalini F, Danti L (1997) Doppler velocimetry of the uterine arteries in nulliparous women. Early Hum Dev 48(1–2):177–185. https://doi.org/10.1016/s0378-3782(96)01854-3CrossRefPubMed

29.

Drukker L, Staines-Urias E, Villar J, Barros FC, Carvalho M, Munim S, McGready R, Nosten F, Berkley JA, Norris SA, Uauy R, Kennedy SH, Papageorghiou AT (2020) International gestational age-specific centiles for umbilical artery Doppler indices: a longitudinal prospective cohort study of the INTERGROWTH-21^st Project. Am J Obstet Gynecol 222(6):602.e1-602.e15. https://doi.org/10.1016/j.ajog.2020.01.012CrossRefPubMed

30.

Lees CC, Stampalija T, Baschat A, da Silva CF, Ferrazzi E, Figueras F, Hecher K, Kingdom J, Poon LC, Salomon LJ, Unterscheider J (2020) ISUOG practice guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction. Ultrasound Obstet Gynecol 56(2):298–312. https://doi.org/10.1002/uog.22134CrossRefPubMed

31.

ACOG Practice Bulletin No. 202 (2019) Gestational hypertension and preeclampsia. Obstet Gynecol 133(1):1. https://doi.org/10.1097/AOG.0000000000003018CrossRef

32.

Bertino E, Spada E, Occhi L, Coscia A, Giuliani F, Gagliardi L, Gilli G, Bona G, Fabris C, De Curtis M, Milani S (2010) Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr 51(3):353–361. https://doi.org/10.1097/MPG.0b013e3181da213eCrossRefPubMed

33.

Rolnik DL, Wright D, Poon LCY, Syngelaki A, O’Gorman N, de Paco MC, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH (2017) ASPRE trial: performance of screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol 50(4):492–495. https://doi.org/10.1002/uog.18816CrossRefPubMed

34.

Guttmacher AE, Maddox YT, Spong CY (2014) The Human Placenta Project: placental structure, development, and function in real time. Placenta 35(5):303–304. https://doi.org/10.1016/j.placenta.2014.02.012CrossRefPubMedPubMedCentral

35.

Cartwright JE, Fraser R, Leslie K, Wallace AE, James JL (2010) Remodelling at the maternal-fetal interface: relevance to human pregnancy disorders. Reproduction 140(6):803–813. https://doi.org/10.1530/REP-10-0294CrossRefPubMed

36.

Vasilopoulou E, Loubière LS, Lash GE, Ohizua O, McCabe CJ, Franklyn JA, Kilby MD, Chan SY (2014) Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner. Hum Reprod 29(6):1161–1172. https://doi.org/10.1093/humrep/deu046CrossRefPubMedPubMedCentral

37.

Wu MQ, Liu J, Wang YQ, Yang Y, Yan CH, Hua J (2019) The impact of subclinical hypothyroidism on adverse perinatal outcomes and the role of thyroid screening in pregnancy. Front Endocrinol (Lausanne) 6(10):522. https://doi.org/10.3389/fendo.2019.00522CrossRef

38.

Chen LM, Du WJ, Dai J, Zhang Q, Si GX, Yang H, Ye EL, Chen QS, Yu LC, Zhang C, Lu XM (2014) Effects of subclinical hypothyroidism on maternal and perinatal outcomes during pregnancy: a single-center cohort study of a Chinese population. PLoS One 9(10):e109364. https://doi.org/10.1371/journal.pone.0109364CrossRefPubMedPubMedCentral

39.

Yuan N, Sun J, Zhao X, Du J, Nan M, Zhang Q, Zhang X (2022) Untreated thyroid autoantibody-negative SCH increases the risk of spontaneous abortions. Endocr Connect 11(4):e210600. https://doi.org/10.1530/EC-21-0600CrossRefPubMedPubMedCentral

40.

De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, Eastman CJ, Lazarus JH, Luton D, Mandel SJ, Mestman J, Rovet J, Sullivan S (2012) Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(8):2543–2565. https://doi.org/10.1210/jc.2011-2803CrossRefPubMed

41.

Azizi F, Amouzegar A (2011) Management of hyperthyroidism during pregnancy and lactation. Eur J Endocrinol 164(6):871–876. https://doi.org/10.1530/EJE-10-1030CrossRefPubMed

42.

Monen L, Kuppens SM, Hasaart TH, Oosterbaan HP, Oei SG, Wijnen H, Hutton EK, Vader HL, Pop VJ (2015) Maternal thyrotropin is independently related to small for gestational age neonates at term. Clin Endocrinol (Oxf) 82(2):254–259. https://doi.org/10.1111/cen.12578CrossRefPubMed

43.

Maraka S, Ospina NM, O’Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ, Coddington CC 3rd, Stan MN, Murad MH, Montori VM (2016) Subclinical hypothyroidism in pregnancy: a systematic review and meta-analysis. Thyroid 26(4):580–590. https://doi.org/10.1089/thy.2015.0418CrossRefPubMedPubMedCentral

44.

Amouzegar A, Pearce EN, Mehran L, Lazarus J, Takyar M, Azizi F (2022) TPO antibody in euthyroid pregnant women and cognitive ability in the offspring: a focused review. J Endocrinol Invest 45(2):425–431. https://doi.org/10.1007/s40618-021-01664-8CrossRefPubMed

45.

McCowan L, Horgan RP (2009) Risk factors for small for gestational age infants. Best Pract Res Clin Obstet Gynaecol 23(6):779–793. https://doi.org/10.1016/j.bpobgyn.2009.06.003CrossRefPubMed

46.

Campbell MK, Cartier S, Xie B, Kouniakis G, Huang W, Han V (2012) Determinants of small for gestational age birth at term. Paediatr Perinat Epidemiol 26(6):525–533. https://doi.org/10.1111/j.1365-3016.2012.01319.xCrossRefPubMed

47.

Derakhshan A, Peeters RP, Taylor PN et al (2020) Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis. Lancet Diabetes Endocrinol 8(6):501–510. https://doi.org/10.1016/S2213-8587(20)30061-9CrossRefPubMedPubMedCentral

48.

Amiri M, Nazarpour S, Ramezani Tehrani F, Sheidaei A, Azizi F (2022) The targeted high-risk case-finding approach versus universal screening for thyroid dysfunction during pregnancy: thyroid-stimulating hormone (TSH) and/or thyroid peroxidase antibody (TPOAb) test? J Endocrinol Investig 45(9):1641–1651. https://doi.org/10.1007/s40618-021-01738-7CrossRef

49.

Peng CC, Pearce EN (2022) An update on thyroid disorders in the postpartum period. J Endocrinol Investig 45(8):1497–1506. https://doi.org/10.1007/s40618-022-01762-1CrossRef

50.

Elfström P, Montgomery SM, Kämpe O, Ekbom A, Ludvigsson JF (2008) Risk of thyroid disease in individuals with celiac disease. J Clin Endocrinol Metab 93(10):3915–3921. https://doi.org/10.1210/jc.2008-0798CrossRefPubMed

51.

Betterle C, Lazzarotto F, Presotto F (2004) Autoimmune polyglandular syndrome Type 2: the tip of an iceberg? Clin Exp Immunol 137(2):225–233. https://doi.org/10.1111/j.1365-2249.2004.02561.xCrossRefPubMedPubMedCentral

52.

Molitch ME, Gillam MP (2007) Lymphocytic hypophysitis. Horm Res 68(Suppl 5):145–150. https://doi.org/10.1159/000110611CrossRefPubMed

53.

Rotondi M, Cappelli C, Leporati P, Chytiris S, Zerbini F, Fonte R, Magri F, Castellano M, Chiovato L (2010) A hypoechoic pattern of the thyroid at ultrasound does not indicate autoimmune thyroid diseases in patients with morbid obesity. Eur J Endocrinol 163(1):105–109. https://doi.org/10.1530/EJE-10-0288CrossRefPubMed

54.

Ekinci EI, Chiu WL, Lu ZX, Sikaris K, Churilov L, Bittar I, Lam Q, Crinis N, Houlihan CA (2015) A longitudinal study of thyroid autoantibodies in pregnancy: the importance of test timing. Clin Endocrinol (Oxf) 82(4):604–610. https://doi.org/10.1111/cen.12571CrossRefPubMed

Titel: A first-trimester serum TSH in the 4–10 mIU/L range is associated with obstetric complications in thyroid peroxidase antibody-negative women
verfasst von: F. Magri
C. Bellingeri
I. De Maggio
L. Croce
F. Coperchini
M. Rotondi
L. Chiovato
A. Spinillo
F. Beneventi
Publikationsdatum: 01.07.2023
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 7/2023
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-022-01996-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

NSCLC: Progressionsfreies Überleben unter Osimertinib fast versiebenfacht

06.06.2024 ASCO 2024 Kongressbericht

Erste Ergebnisse der Phase-III-Studie LAURA etablieren Osimertinib als neuen Therapiestandard für Menschen mit nicht-resezierbarem, EGFR-mutiertem, nicht-kleinzelligem Lungenkarzinom im Stadium III, die nach definitiver Radiochemotherapie progressionsfrei sind. Auf der ASCO-Tagung wurden diese beeindruckenden Ergebnisse besprochen.

Hodgkin Lymphom: BrECADD-Regime übertrifft die Erwartungen

05.06.2024 ASCO 2024 Kongressbericht

Das Kombinationsregime BrECADD mit Brentuximab vedotin ermöglichte in der Studie HD21 beim fortgeschrittenen klassischen Hodgkin-Lymphom eine unerwartet hohe progressionsfreie Überlebensrate von 94,3% nach vier Jahren. Gleichzeitig war das Regime besser tolerabel als der bisherige Standard eBEACOPP.

Antikörper-Drug-Konjugat verdoppelt PFS bei Multiplem Myelom

05.06.2024 ASCO 2024 Nachrichten

Zwei Phase-3-Studien deuten auf erhebliche Vorteile des Antikörper-Wirkstoff-Konjugats Belantamab-Mafodotin bei vorbehandelten Personen mit Multiplem Myelom: Im Vergleich mit einer Standard-Tripeltherapie wurde das progressionsfreie Überleben teilweise mehr als verdoppelt.

Neuer TKI gegen CML: Höhere Wirksamkeit, seltener Nebenwirkungen

05.06.2024 Chronische myeloische Leukämie Nachrichten

Der Tyrosinkinasehemmer (TKI) Asciminib ist älteren Vertretern dieser Gruppe bei CML offenbar überlegen: Personen mit frisch diagnostizierter CML entwickelten damit in einer Phase-3-Studie häufiger eine gute molekulare Response, aber seltener ernste Nebenwirkungen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Adipositas in der Primärversorgung – Herausforderungen und Chancen einer ganzheitlichen Betreuung

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2023

The potent contraceptive gestodene exerts insulinotropic effects through its a-ring reduced metabolites with intrinsic estrogen-like activity in pancreatic β-cells

The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States

Dysthyroid optic neuropathy: emerging treatment strategies

The association between dietary selenium intake and Hashimoto’s thyroiditis among US adults: National Health and Nutrition Examination Survey (NHANES), 2007–2012

Development and validation of a nomogram to predict poor short-term response to recombinant human growth hormone treatment in children with growth disorders